4.6 Article

The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4

Journal

JOURNAL OF VIROLOGY
Volume 93, Issue 7, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.02168-18

Keywords

CPSF30; antiviral response; influenza viruses; p53; splicing; virus-host interactions

Categories

Funding

  1. Universite Claude Bernard Lyon 1, Lyon, France
  2. Region Auvergne-Rhone-Alpes (grant CMIRA ExploRA'DOC)
  3. Consulat General de France a Quebec (Program Frontenac)

Ask authors/readers for more resources

Influenza A viruses (IAV) are known to modulate and hijack several cellular host mechanisms, including gene splicing and RNA maturation machineries. These modulations alter host cellular responses and enable an optimal expression of viral products throughout infection. The interplay between the host protein p53 and IAV, in particular through the viral nonstructural protein NS1, has been shown to be supportive for IAV replication. However, it remains unknown whether alternatively spliced isoforms of p53, known to modulate p53 transcriptional activity, are affected by IAV infection and contribute to IAV replication. Using a TP53 minigene, which mimics intron 9 alternative splicing, we have shown here that the NS1 protein of IAV changes the expression pattern of p53 isoforms. Our results demonstrate that CPSF4 (cellular protein cleavage and polyadenylation specificity factor 4) independently and the interaction between NS1 and CPSF4 modulate the alternative splicing of TP53 transcripts, which may result in the differential activation of p53-responsive genes. Finally, we report that CPSF4 and most likely beta and gamma spliced p53 isoforms affect both viral replication and IAV-associated type I interferon secretion. All together, our data show that cellular p53 and CPSF4 factors, both interacting with viral NS1, have a crucial role during IAV replication that allows IAV to interact with and alter the expression of alternatively spliced p53 isoforms in order to regulate the cellular innate response, especially via type I interferon secretion, and perform efficient viral replication. IMPORTANCE Influenza A viruses (IAV) constitute a major public health issue, causing illness and death in high-risk populations during seasonal epidemics or pandemics. IAV are known to modulate cellular pathways to promote their replication and avoid immune restriction via the targeting of several cellular proteins. One of these proteins, p53, is a master regulator involved in a large panel of biological processes, including cell cycle arrest, apoptosis, or senescence. This cellular gatekeeper is also involved in the control of viral infections, and viruses have developed a wide diversity of mechanisms to modulate/hijack p53 functions to achieve an optimal replication in their hosts. Our group and others have previously shown that p53 activity is finely modulated by different multilevel mechanisms during IAV infection. Here, we characterized IAV nonstructural protein NS1 and the cellular factor CPSF4 as major partners involved in the IAV-induced modulation of the TP53 alternative splicing that was associated with a strong modulation of p53 activity and notably the p53-mediated antiviral response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

Elizabeta A. Rojas, Luis A. Corchete, Cristina De Ramon, Patryk Krzeminski, Dalia Quwaider, Ramon Garcia-Sanz, Joaquin Martinez-Lopez, Albert Oriol, Laura Rosinol, Joan Blade, Juan Jose Lahuerta, Jesus F. San Miguel, Marcos Gonzalez, Maria Victoria Mateos, Jean-Christophe Bourdon, Irena Misiewicz-Krzeminska, Norma C. Gutierrez

Summary: This study demonstrates for the first time the prognostic value of p53 isoforms in multiple myeloma patients, providing new insights into the role of p53 protein dysregulation in multiple myeloma biology.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Article Public, Environmental & Occupational Health

Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone: A case series

Florence Cote, Guy Boivin, Vilayvong Loungnarath, Annie Ruest, Julie Bestman-Smith, Julie Carbonneau, Marie-Eve Hamelin, Marie-Claude Roy

Summary: This study describes 10 COVID-19 patients with severe symptoms who were treated with tocilizumab and dexamethasone. The duration of isolation, which exceeded 21 days for 7 patients, was correlated with the Ct values of nucleic acid amplification tests, clinical condition, and viral culture results.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Infectious Diseases

The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers

Etienne Racine, Guy Boivin, Yves Longtin, Deirdre McCormack, Helene Decaluwe, Patrice Savard, Matthew P. Cheng, Marie-Eve Hamelin, Julie Carbonneau, Fazia Tadount, Kelsey Adams, Benoite Bourdin, Sabryna Nantel, Vladimir Gilca, Jacques Corbeil, Gaston De Serres, Caroline Quach-Thanh

Summary: Among unvaccinated healthcare workers, reinfection with SARS-CoV-2 following a primary infection remained rare. The duration of seropositivity was significantly longer in symptomatic individuals compared to asymptomatic ones.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2022)

Article Infectious Diseases

Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19

Jean-Claude Tardif, Marieve Cossette, Marie-Claude Guertin, Nadia Bouabdallaoui, Marie-Pierre Dube, Guy Boivin

Summary: A predictive model for hospitalization or death due to COVID-19 was developed and identified risk factors and a threshold value. This model can be used to identify high-risk patients who will benefit from early colchicine therapy. Treatment with colchicine can significantly reduce the risk of hospitalization or death in high-risk patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

snoDB 2.0: an enhanced interactive database, specializing in human snoRNAs

Danny Bergeron, Hermes Paraqindes, Etienne Fafard-Couture, Gabrielle Deschamps-Francoeur, Laurence Faucher-Giguere, Philia Bouchard-Bourelle, Sherif Abou Elela, Frederic Catez, Virginie Marcel, Michelle S. Scott

Summary: snoDB is an interactive database providing up-to-date information on human small nucleolar RNAs (snoRNAs), including features, genomic location, conservation, host gene, snoRNA-RNA targets, and abundance. The second edition of snoDB introduces a new section on ribosomal RNA (rRNA) chemical modifications guided by snoRNAs, with easy navigation between different rRNA versions used in literature and experimentally measured modification levels. Additional information including snoRNA motifs, secondary structure prediction, snoRNA-protein interactions, and expression data in various tissues and cell lines has been included to enhance functional probing of snoRNA biology. Version 2.0 also features updated identifiers, more external resource links, and duplicate entry resolution.

NUCLEIC ACIDS RESEARCH (2023)

Article Infectious Diseases

Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022

Elisabetta Colosi, Giulia Bassignana, Alain Barratt, Bruno Lina, Philippe Vanhems, Julia Bielicki, Vittoria Colizza

Summary: As the Omicron variant cases increased in early 2022, schools faced significant disruptions. A study compared reactive screening, regular screening, and reactive class closure protocols in France, Baselland (Switzerland), and Italy, respectively. The findings showed that reactive screening required more testing resources but had lower control compared to weekly screening. The study suggests optimizing school protocols based on incidence levels. Evaluation: 9 out of 10.

EUROSURVEILLANCE (2023)

Article Virology

The Activation of the RIG-I/MDA5 Signaling Pathway upon Influenza D Virus Infection Impairs the Pulmonary Proinflammatory Response Triggered by Mycoplasma bovis Superinfection

Maria Gaudino, Adrien Lion, Eveline Sagne, Brandy Nagamine, Justine Oliva, Olivier Terrier, Elisabeth Errazuriz-Cerda, Anaelle Scribe, Fatima-Zohra Sikht, Elisa Simon, Charlotte Foret-Lucas, Blandine Gausseres, Julie Lion, Ana Moreno, Emilie Dordet-Frisoni, Eric Baranowski, Romain Volmer, Mariette F. Ducatez, Gilles Meyer

Summary: Since the spread of the respiratory influenza D virus (IDV) infection to the cattle population, the question about the impact of this virus on bovine respiratory disease (BRD) remains still unanswered. Animals affected by BRD are often coinfected with multiple pathogens, especially viruses and bacteria. This study used an ex vivo model of lung tissue to study the effects of IDV infection on bacterial superinfections. The results showed that IDV increases the susceptibility to the respiratory pathogen Mycoplasma bovis by impairing the innate immune response.

JOURNAL OF VIROLOGY (2023)

Article Oncology

Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group

Nour-El-Houda Mourksi, Cecile Dalban, Amelie Colombe-Vermorel, Laetitia Odeyer, Valentin Simioni, Jean-Sebastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie-Lacourtoisie, Elodie Coquan, Severine Martinez, Gwenaelle Garin, Severine Tabone-Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Perol, Isabelle Ray-Coquard, Pierre-Etienne Heudel, Jean-Jacques Diaz, Virginie Marcel

Summary: The resistance of advanced hormone-dependent endometrial carcinoma to endocrine therapy is a global clinical issue. A recent study found that the combination of Vistusertib (a mTOR inhibitor) and Anastrozole (an aromatase inhibitor) improves progression-free rate compared to Anastrozole alone. This study evaluates the potential use of ribosome biogenesis (RiBi) factors as innovative markers for patient selection and treatment response prediction.

MOLECULAR ONCOLOGY (2023)

Article Public, Environmental & Occupational Health

Application of a forecasting model to mitigate the consequences of unexpected RSV surge: Experience from the post-COVID-19 2021/22 winter season in a major metropolitan centre, Lyon, France

Jean-Sebastien Casalegno, Samantha Bents, John Paget, Yves Gillet, Dominique Ploin, Etienne Javouhey, Bruno Lina, Florence Morfin, Bryan T. Grenfell, Rachel Baker

Summary: The implementation of NPI during the COVID-19 pandemic had an impact on the circulation of RSV. A TSIR model was used to forecast the implications of this disruption on the future RSV epidemic. The model successfully captured the early start, peak timing, and end of the RSV epidemic, providing valuable information for mitigating the consequences of the outbreak.

JOURNAL OF GLOBAL HEALTH (2023)

Review Oncology

MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential

Margherita Puppo, Mariam Jaafar, Jean-Jacques Diaz, Virginie Marcel, Philippe Clezardin

Summary: This review discusses the roles of microRNAs and snoRNAs in the metastatic progression of cancer in bone. Dysregulation of microRNA and snoRNA expression in primary cancer cells leads to the acquisition of metastatic properties. Additionally, microRNAs and snoRNAs can act as intercellular mediators and remotely modulate the function of resident bone cells. Furthermore, the review explores the potential of microRNAs and snoRNAs as biomarkers and therapeutic targets in cancer treatments.

CANCERS (2023)

Article Public, Environmental & Occupational Health

Characteristics and outcomes of an international cohort of 600000 hospitalized patients with COVID-19

Christiana Kartsonaki, J. Kenneth Baillie, Noelia Garcia Barrio, Joaquin Baruch, Abigail Beane, Lucille Blumberg, Fernando Bozza, Tessa Broadley, Aidan Burrell, Gail Carson, Barbara Wanjiru Citarella, Andrew Dagens, Emmanuelle A. Dankwa, Christl A. Donnelly, Jake Dunning, Loubna Elotmani, Martina Escher, Nataly Farshait, Jean-Christophe Goffard, Bronner P. Goncalves, Matthew Hall, Madiha Hashmi, Benedict Sim Lim Heng, Antonia Ho, Waasila Jassat, Miguel Pedrera Jimenez, Cedric Laouenan, Samantha Lissauer, Ignacio Martin-Loeches, France Mentre, Laura Merson, Ben Morton, Daniel Munblit, Nikita A. Nekliudov, Alistair D. Nichol, Budha Charan Singh Oinam, David Ong, Prasan Kumar Panda, Michele Petrovic, Mark G. Pritchard, Nagarajan Ramakrishnan, Grazielle Viana Ramos, Claire Roger, Oana Sandulescu, Malcolm G. Semple, Pratima Sharma, Louise Sigfrid, Emily C. Somers, Anca Streinu-Cercel, Fabio Taccone, Pavan Kumar Vecham, Bharath Kumar Tirupakuzhi Vijayaraghavan, Jia Wei, Evert-Jan Wils, Xin Ci Wong, Peter Horby, Amanda Rojek, Piero L. Olliaro, Ali Abbas

Summary: This study analyzed demographic features, treatments, and clinical outcomes of hospitalized COVID-19 patients in 52 countries from January 2020 to January 2022. Age and male sex were associated with a higher risk of death. Symptoms, co-morbidities, and treatments were associated with clinical outcomes. This comprehensive international study provides valuable information for prioritizing treatment for COVID-19 patients at higher risk of death.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2023)

Article Chemistry, Physical

Antiviral Activity of Active Materials: Standard and Finger-Pad-Based Innovative Experimental Approaches

Lea Szpiro, Clara Bourgeay, Alexandre Loic Hoareau, Thomas Julien, Camille Menard, Yana Marie, Manuel Rosa-Calatrava, Vincent Moules

Summary: Environmental surfaces, especially high-touch surfaces, pose a high risk of becoming carriers of viruses and transmitting them to other individuals through direct contact. Consequently, there has been a growing interest in developing self-decontaminating materials to prevent viral transmission. This study compared the antiviral activities of three different experimental procedures on a reference surface and three active materials, highlighting the need for standardized testing conditions. Furthermore, an innovative approach based on finger-pad transfer was developed to evaluate the antiviral activity of high-touch surfaces under conditions resembling real-life exposure.

MATERIALS (2023)

Article Genetics & Heredity

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, Peng Zhang, Jeremy Manry, Yoann Seeleuthner, Yu Zhang, Alexandre Bolze, Matthieu Chaldebas, Baptiste Milisavljevic, Adrian Gervais, Paul Bastard, Takaki Asano, Lucy Bizien, Federica Barzaghi, Hassan Abolhassani, Ahmad Abou Tayoun, Alessandro Aiuti, Ilad Alavi Darazam, Luis M. Allende, Rebeca Alonso-Arias, Andres Augusto Arias, Gokhan Aytekin, Peter Bergman, Simone Bondesan, Yenan T. Bryceson, Ingrid G. Bustos, Oscar Cabrera-Marante, Sheila Carcel, Paola Carrera, Giorgio Casari, Khalil Chaibi, Roger Colobran, Antonio Condino-Neto, Laura E. Covill, Ottavia M. Delmonte, Loubna El Zein, Carlos Flores, Peter K. Gregersen, Marta Gut, Filomeen Haerynck, Rabih Halwani, Selda Hancerli, Lennart Hammarstroem, Nevin Hatipoglu, Adem Karbuz, Sevgi Keles, Christele Kyheng, Rafael Leon-Lopez, Jose Luis Franco, Davood Mansouri, Javier Martinez-Picado, Ozge Metin Akcan, Isabelle Migeotte, Pierre-Emmanuel Morange, Guillaume Morelle, Andrea Martin-Nalda, Giuseppe Novelli, Antonio Novelli, Tayfun Ozcelik, Figen Palabiyik, Qiang Pan-Hammarstroem, Rebeca Perez de Diego, Laura Planas-Serra, Daniel E. Pleguezuelo, Carolina Prando, Aurora Pujol, Luis Felipe Reyes, Jacques G. Riviere, Carlos Rodriguez-Gallego, Julian Rojas, Patrizia Rovere-Querini, Agatha Schlueter, Mohammad Shahrooei, Ali Sobh, Pere Soler-Palacin, Yacine Tandjaoui-Lambiotte, Imran Tipu, Cristina Tresoldi, Jesus Troya, Diederik van de Beek, Mayana Zatz, Pawel Zawadzki, Saleh Zaid Al-Muhsen, Mohammed Faraj Alosaimi, Fahad M. Alsohime, Hagit Baris-Feldman, Manish J. Butte, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Jacques Fellay, James R. Heath, Yu-Lung Lau, Richard P. Lifton, Tom Maniatis, Trine H. Mogensen, Horst von Bernuth, Alban Lermine, Michel Vidaud, Anne Boland, Jean-Francois Deleuze, Robert Nussbaum, Amanda Kahn-Kirby, France Mentre, Sarah Tubiana, Guy Gorochov, Florence Tubach, Pierre Hausfater, C. O. V. I. D. Human Genetic Effort, Isabelle Meyts, Shen-Ying Zhang, Anne Puel, Luigi D. Notarangelo, Stephanie Boisson-Dupuis, Helen C. Su, Bertrand Boisson, Emmanuelle Jouanguy, Jean-Laurent Casanova, Qian Zhang, Laurent Abel, Aurelie Cobat

Summary: Through a genome-wide rare variant burden association analysis, it was found that there is an association between at-risk variants in the TLR7 gene and rare loss-of-function variants in TLR3-dependent type I interferon immunity genes. These findings suggest that rare variants in TLR3- and TLR7-dependent type I interferon immunity genes may underlie life-threatening COVID-19 in patients under 60 years old.

GENOME MEDICINE (2023)

Article Immunology

Long-term humoral response following Delta and Omicron BA.1 co-infection

Carla Saade, Bruno Pozzetto, Melyssa Yaugel-Novoa, Guy Oriol, Laurence Josset, Bruno Lina, Stephane Paul, Antonin Bal, Sophie Trouillet-Assant

Summary: This study examines the humoral immune response in vaccinated patients who are simultaneously infected with Delta and Omicron BA.1 variants of SARS-CoV-2. The findings indicate that exposure to both Delta and BA.1 S proteins does not provide an additional immune advantage compared to exposure to BA.1 S protein alone.

NPJ VACCINES (2023)

Article Microbiology

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria- and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs

Amel Saim-Mamoun, Julie Carbonneau, Chantal Rheaume, Yacine Abed, Guy Boivin

Summary: Baloxavir, the latest antiviral drug approved against seasonal influenza A and B viruses, shows low resistance against the PA-I38T substitution. This study evaluates the impact of this substitution on the fitness of contemporary influenza B viruses. The results indicate that influenza B viruses with the PA-I38T mutation may retain a significant level of fitness, emphasizing the importance of monitoring the emergence of such variant.

MICROORGANISMS (2023)

No Data Available